Context Therapeutics Inc (CNTX)
2.24
-0.03
(-1.32%)
USD |
NASDAQ |
Nov 04, 16:00
2.27
+0.03
(+1.34%)
After-Hours: 20:00
Context Therapeutics Total Liabilities (Quarterly): 1.604M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.604M |
| March 31, 2024 | 2.608M |
| December 31, 2023 | 4.192M |
| September 30, 2023 | 4.604M |
| June 30, 2023 | 3.757M |
| March 31, 2023 | 3.233M |
| December 31, 2022 | 3.208M |
| September 30, 2022 | 4.012M |
| Date | Value |
|---|---|
| June 30, 2022 | 3.048M |
| March 31, 2022 | 1.638M |
| December 31, 2021 | 3.033M |
| September 30, 2021 | 25.47M |
| June 30, 2021 | 25.02M |
| March 31, 2021 | 19.73M |
| December 31, 2020 | 17.39M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.604M
Minimum
Jun 2024
25.47M
Maximum
Sep 2021
8.170M
Average
3.757M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Collegium Pharmaceutical Inc | 836.80M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 102.71M |
| Shareholders Equity (Quarterly) | 101.10M |